Arun Parthasarathy

Arun Parthasarathy

Auto-generated profile, based on publicly available information

Arun Parthasarathy

Department of Anaesthesiology, Kasturba Medical College, Manipal Academy of Higher Education, Manipal, India

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 October 2025 in Trends in Anaesthesia and Critical Care
Verified
Journal Article
Open access
SASmriti Agrawal
Smriti Agrawal
ADArun Kumar Handigodu Duggappa
Arun Kumar Handigodu Duggappa
DPDr Suvajit Podder
Dr Suvajit Podder
DSDeepali Shetty
Deepali Shetty
SSShweta Sinha
Shweta Sinha
HSHemamalini Sridharan
Hemamalini Sridharan

9 July 2026 in Journal of Pharmacology and Pharmacotherapeutics
Verified
Journal Article
Open access
HSHemamalini Sridharan
Hemamalini Sridharan
APArun Parthasarathy
Arun Parthasarathy
DDDiksha Dmello
Diksha Dmello
SPSachin Sogal P
Sachin Sogal P
SPSuvajit Podder
Suvajit Podder
ADAnula Dsouza
Anula Dsouza
Background: Regional anaesthesia is widely preferred for upper limb surgeries, particularly those performed below the elbow; however, the limited duration of action of local anaesthetics remains a clinical challenge. The addition of adjuvants such as magnesium sulphate (MgSO 4 ) contributes to better block characteristics and sustained analgesic effect. Objectives: This study was designed to investigate whether varying doses of perineural MgSO 4 influence the characteristics of ultrasound-guided infraclavicular brachial plexus block performed with bupivacaine. Materials and Methods: Following approval from the Institutional Ethics Committee and registration with the Clinical Trials Registry-India, this prospective randomised double-blind single-centre study was undertaken in 90 ASA I-II adults undergoing elective upper limb surgery. Participants were randomly allocated into three groups ( n = 30 each). All groups received 20 mL of 0.5% bupivacaine, with Group A receiving 125 mg MgSO 4 , Group B 250 mg MgSO 4 and Group C 500 mg MgSO 4 , diluted with normal saline to maintain equal volume. The principal outcome measure was postoperative analgesia duration, with block characteristics and adverse events analysed as secondary outcomes. Continuous variables were analysed using one-way analysis of variance, and categorical variables using the Chi-square test. Results: The duration of analgesia increased significantly in a dose-dependent manner, with Group C demonstrating the longest duration (711 ± 38.98 min), followed by Group B (582.17 ± 29.64 min) and Group A (466.33 ± 32 min) ( p < .001). Sensory and motor blockade developed more rapidly and persisted longer in Group C than in the other two groups. None of the participants experienced block failure or adverse effects such as hypotension, bradycardia, nausea or vomiting. Conclusion: Perineural MgSO 4 significantly enhances the duration of analgesia and improves block characteristics in ultrasound-guided infraclavicular brachial plexus block in a dose-dependent manner. Among the doses studied, 500 mg MgSO 4 provided the most prolonged analgesia without increasing adverse effects, supporting its safe and effective use as an adjuvant to bupivacaine in upper limb surgeries.